Lori McMullen, RN, MSN, OCN, Senior Oncology Nurse Navigator, University Medical Center of Princeton at Plainsboro, discusses the next step in nurse navigation.
Blake A. Morrison, PharmD, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses adverse events associated with new agents to treat patients with multiple myeloma.
Julia Whiteker Describes the ONS Breast Care SIG Online Community
Barbara Daly, PhD, RN, FAAN, and Helen Foley, MSN, AOCNS®, offer highlights of their institution's oncology and palliative care program, which successfully prepares graduates to assume advanced practice roles in these important areas.
In fall of 2009, Smilow Cancer Hospital at Yale-New Haven opened a new, state-of-theart, 15-story, clinical facility with the latest advances in diagnostic, therapeutic, and surveillance procedures.
You are the worldâ€™s leading authority on your life and work. When mapping a plan for working through treatment, itâ€™s important to marry your expertise with that of various members of your healthcare team.
G. Thomas Budd, MD, medical oncologist, Taussig Cancer Center at Cleveland Clinic, discusses genomic profiling for targeted therapies.
The anti-vaccination movement is causing outbreaks around the world, and may be even more dangerous for patients with cancer.
Sandra Ruland, RN, OCN, says she has to strike a delicate balance when talking to patients about how they use the internet to research their cancer.
Change is the one word that describes an immediate result of a cancer diagnosis. A patient’s world can be turned upside down, and they could end up facing obstacles including dietary changes, role changes within their family, and even changes in their activities of daily living.
At the 3rd annual School of Nursing Oncology (SONO) meeting, we got the chance to sit down with Madelaine Kuiper RN, MSN, and talk about what adverse events come with immune therapy for patients with breast cancer.
Oncology nurses’ intimate knowledge of their patients’ situations can enable them to match patients' needs to the appropriate resources.
Lisa Butterfield discusses what nurses should know when treating patients receiving immunotherapies.
Dr. Ken Fleisher from New York University Discusses Monitoring Patients With ONJ
Rajni Kannan, BS, MS, RN, APN-BC, discusses the management of patients receiving combination immunotherapy.
Nurse navigators at Sarah Cannon use oncology pathways to help ensure patient access to seamless care across the cancer continuum.
"What's your opinion about using hair color?" I asked my doctor shortly before beginning chemotherapy. "I don't have an opinion," he said. "Talk to one of the nurses."
Celestia S. Higano, MD, of the Seattle Cancer Care Alliance, discusses sexual health services that are available to survivors of prostate cancer.
Alicia Staley on the importance of making clinical trials accessible for patients.
Benjamin Levy, MD, medical director, Thoracic Oncology, Mount Sinai Health System, discusses recent advances in the detection and diagnosis of lung cancer.
Joel Stettler, BSN, RN, OCN, Moffitt Cancer Center, discusses common causes for falls in the inpatient malignant hematology population, and what can be done to reduce these incidents.
Oncology nurses are key in enrolling and helping patients through clinical trials.
Mary Cooley, PhD, APRN, BC, nurse scientist, Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, discusses issues with monitoring symptoms and patient preferences electronically.
Rapid changes occurring nationally and worldwide—including shifts in demographics, languages, epidemiological patterns, and social systems— have direct implications for patient care. These trends are projected to continue, and nurses need to be prepared to care for increasingly diverse patient populations.
Dawn Frambes, PhD, RN, discusses the importance of involving the caregivers (and other friends and family) in the delivery of treatments for symptom management.
Seasoned nurses know the ins and outs of the job, therefore they can be the best resource for those who are just beginning their career.
Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treating different subsets of bladder cancer.